Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
Antonio Molinaro(Federico II University Hospital), Soraya Fellahi(Inserm), Marcus Henricsson(University of Gothenburg), Karen E. Assmann(Inserm), Sara Vieira‐Silva(Rega Institute for Medical Research), Chloé Amouyal(Inserm), Trine Nielsen, Magali Berland(Université Paris-Saclay), Sofia K. Forslund(Max Delbrück Center), Sébastien André(Inserm), Edi Prifti(Institut National de la Recherche Agronomique), Eugeni Belda(Inserm), Helle Pedersen(University of Copenhagen), Solia Adriouch(Inserm), Cécile Ciangura(Sorbonne Université), Dominique Adèle Cassuto(Hôtel-Dieu de Paris), Rima Chakaroun(Sahlgrenska University Hospital), Gwen Falony(Rega Institute for Medical Research), Maria Carlota Dao(Inserm), Renato Alves(Instituto Gulbenkian de Ciência), Randa Bittar(Inserm), Luís Pedro Coelho(Queensland University of Technology), Line Engelbrechtsen(Inserm), Hervé M. Blottière(Institut National de la Recherche Agronomique), Benoît Quinquis(Université Paris-Saclay), Hao Wu(Stanford Medicine), Tue H. Hansen(University of Copenhagen), Julien Chilloux(Imperial College London), Joe‐Elie Salem(Inserm), Angélique Doré(Université Paris-Saclay), Pierre Bel Lassen(Inserm), Olivier Bourron(Inserm), Hugo Roume(Université Paris-Saclay), Jean‐Philippe Collet(Inserm), Ehm Astrid Andersson Galijatovic(University of Copenhagen), Olivier Barthélemy(Sorbonne Université), Per-Olof Bergh(Sahlgrenska University Hospital), Fabrizio Andreelli(Inserm), Emmanuelle Le Chatelier(AgroParisTech), Morad Djebbar(Sorbonne Université), Nicolas Pons(AgroParisTech), Jean‐Philippe Bastard(Hôpitaux Universitaires Henri-Mondor), Nadja B. Sønderskov(University of Copenhagen), Mickaël Camus(Université Paris-Saclay), Christine Rouault(Inserm), F Bosquet(Sorbonne Université), Florian Marquet(Inserm), Rachid Boubrit(Sorbonne Université), Christian Lewinter(University of Copenhagen), Jean-Paul Batisse(Sorbonne Université)
Cited by 275
Related Papers
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Richness of human gut microbiome correlates with metabolic markers
|Nature|2013|4.7k